How effective is Mefloquine Hydrochloride for Quartan Malaria (Malaria)? (by duration, gender, age)

Summary:

Overall ratings: 3.2/5
Long term ratings: 5/5

This is a phase IV clinical study of how effective Mefloquine hydrochloride (mefloquine hydrochloride) is for Quartan malaria and for what kind of people. The study is created by eHealthMe from 6 Mefloquine hydrochloride users and is updated continuously.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.


On Nov, 06, 2022

6 people are studied for taking Mefloquine hydrochloride in Quartan malaria


What is Mefloquine hydrochloride?

Mefloquine hydrochloride has active ingredients of mefloquine hydrochloride. It is often used in malaria. eHealthMe is studying from 197 Mefloquine hydrochloride users for its effectiveness, alternative drugs and more.

What is Quartan malaria?

Quartan malaria (an infectious disease characterized by cycles of chills, fever, and sweating, caused by a protozoan of the genus plasmodium in red blood cells) is found to be associated with 388 drugs and 306 conditions by eHealthMe.

Overall effectiveness (number of people):

Does Mefloquine hydrochloride work for your Quartan malaria (overall)?

Long term (1+ years) effectiveness (number of people):

Does Mefloquine hydrochloride work for your Quartan malaria (long term)?

Mefloquine hydrochloride effectiveness for Quartan malaria (number of people):

Overall:
  • not at all: 1
  • somewhat: 2
  • moderate: 0
  • high: 1
  • very high: 2
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 0
  • high: 0
  • very high: 1

Gender of people who take Mefloquine hydrochloride for Quartan malaria *:

  • female: 50 %
  • male: 50 %

Age of people who take Mefloquine hydrochloride for Quartan malaria *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 16.67 %
  • 20-29: 0.0 %
  • 30-39: 50.0 %
  • 40-49: 16.67 %
  • 50-59: 16.67 %
  • 60+: 0.0 %

Who find Mefloquine Hydrochloride more effective for Quartan Malaria?

Gender of people who take Mefloquine hydrochloride for Quartan malaria *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who take Mefloquine hydrochloride for Quartan malaria *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 66.67 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Mefloquine hydrochloride?

- You can start a phase IV clinical trial to monitor Mefloquine hydrochloride safety and effectiveness.

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on mefloquine hydrochloride (the active ingredients of Mefloquine hydrochloride) and Mefloquine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: